Concepedia

Tsuneji Suzuki

TS

10

Publications

1.5K

Citations

10

H-Index

1983

Active since

Affiliations

Tokyo Institute of Technology(Current)

The University of Tokyo

Japanese Foundation For Cancer Research

Kanagawa University

Mitsui Chemicals (Germany)

Tsuneji Suzuki is an author at Tokyo Institute of Technology specializing in pharmacology, medicine, and biochemistry.

Top concepts

Publications per year

1983–2002

10

Publications

10

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked <i>in vivo</i> antitumor activity against human tumors

Akiko Saito, Takashi Yamashita, Yukiyasu Mariko et al. · Proceedings of the National Academy of Sciences · 1999 · 696 citations · Full text

Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide Derivatives

Tsuneji Suzuki, Tomoyuki Ando, Katsutoshi Tsuchiya et al. · Journal of Medicinal Chemistry · 1999 · 287 citations · Full text

Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.

Hiroyuki Seimiya, Tomoko Oh‐hara, Tsuneji Suzuki et al. · PubMed · 2002 · 138 citations

, , +18

Structure−Activity Relationship of Newly Synthesized Quinoline Derivatives for Reversal of Multidrug Resistance in Cancer

Tsuneji Suzuki, Nobuyuki Fukazawa, K. SAN‐NOHE et al. · Journal of Medicinal Chemistry · 1997 · 95 citations

Oxidative Removal of <i>N</i>-(4-Methoxybenzyl) Group on 2,5-Piperazinediones with Cerium(IV) Diammonium Nitrate

Masanori Yamaura, Tsuneji Suzuki, Hironobu Hashimoto et al. · Bulletin of the Chemical Society of Japan · 1985 · 60 citations

Rows per page

1–5 of 10